Literature DB >> 21087194

Selection of behaviors and segmental coordination during larval locomotion is disrupted by nuclear polyglutamine inclusions in a new Drosophila Huntington's disease-like model.

Yoichi Nishimura1, Cagri Yalgin, Saori Akimoto, Joanna Doumanis, Ruiko Sasajima, Nobuyuki Nukina, Hiroyoshi Miyakawa, Adrian W Moore, Takako Morimoto.   

Abstract

Huntington's disease is an autosomal dominant neurodegenerative disorder that is caused by abnormal expansion of a polyglutamine tract in the huntingtin protein, resulting in intracellular aggregate formation and neurodegeneration. How neuronal cells are affected by such a polyglutamine tract expansion remains obscure. To dissect the ways in which polyglutamine expansion can cause neural dysfunction, the authors generated Drosophila transgenic strains expressing either a nuclear targeted or cytoplasmic form of pathogenic (NHtt-152Q(NLS), NHtt-152Q), or nonpathogenic (NHtt-18Q(NLS), NHtt-18Q) N-terminal human huntingtin. These proteins were expressed in the dendritic arborization neurons of the larval peripheral nervous system and their effects on neuronal survival, morphology, and larval locomotion were examined. The authors found that NHtt-152Q(NLS) larvae had altered dendrite morphology and larval locomotion, whereas NHtt-152Q, NHtt-18Q(NLS), and NHtt-18Q larvae did not. Furthermore, the authors examined the physiological defect underlying this disrupted larval locomotion in detail by recording spontaneous ongoing segmental nerve activity. NHtt-152Q(NLS) larvae displayed uncoordinated activity between anterior and posterior segments. Moreover, anterior segments had shorter bursts and longer interburst intervals in NHtt-152Q(NLS) larvae than in NHtt-18Q(NLS) larvae, whereas posterior segments had longer bursts and shorter interburst intervals. These results suggest that the pathogenic protein disrupts neuron function without inducing cell death, and describe how this dysfunction leads to a locomotor defect. These results also suggest that sensory inputs are necessary for the coordination of anterior and posterior body parts during locomotion. From these analyses the authors show that examination of motor behaviors in the Drosophila larvae is a powerful new model to dissect non-cell-lethal mechanisms of mutant Htt toxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087194     DOI: 10.3109/01677063.2010.514367

Source DB:  PubMed          Journal:  J Neurogenet        ISSN: 0167-7063            Impact factor:   1.250


  6 in total

1.  Pathogenic polyglutamine proteins cause dendrite defects associated with specific actin cytoskeletal alterations in Drosophila.

Authors:  Sung Bae Lee; Joshua A Bagley; Hye Young Lee; Lily Yeh Jan; Yuh-Nung Jan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  Immunohistological labeling of microtubules in sensory neuron dendrites, tracheae, and muscles in the Drosophila larva body wall.

Authors:  Cagri Yalgin; M Rezaul Karim; Adrian W Moore
Journal:  J Vis Exp       Date:  2011-11-10       Impact factor: 1.355

3.  Morphological analysis of Drosophila larval peripheral sensory neuron dendrites and axons using genetic mosaics.

Authors:  M Rezaul Karim; Adrian W Moore
Journal:  J Vis Exp       Date:  2011-11-07       Impact factor: 1.355

Review 4.  Drosophila as an In Vivo Model for Human Neurodegenerative Disease.

Authors:  Leeanne McGurk; Amit Berson; Nancy M Bonini
Journal:  Genetics       Date:  2015-10       Impact factor: 4.562

5.  Rab11 rescues synaptic dysfunction and behavioural deficits in a Drosophila model of Huntington's disease.

Authors:  Joern R Steinert; Susanna Campesan; Paul Richards; Charalambos P Kyriacou; Ian D Forsythe; Flaviano Giorgini
Journal:  Hum Mol Genet       Date:  2012-03-30       Impact factor: 6.150

6.  Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.

Authors:  Carlo Breda; Korrapati V Sathyasaikumar; Shama Sograte Idrissi; Francesca M Notarangelo; Jasper G Estranero; Gareth G L Moore; Edward W Green; Charalambos P Kyriacou; Robert Schwarcz; Flaviano Giorgini
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.